Why train them as one service
Modern NHS Blood Sciences laboratories run as integrated services. A trainee or rotating BMS needs to understand handovers between haematology, biochemistry and coagulation — especially for critical-result management, transfusion crossover, and major haemorrhage scenarios.
The biggest training gap is not knowledge of any single discipline — it is reasoning across the boundaries. A low haemoglobin needs context from coagulation (active bleeding?) and biochemistry (haemolysis pattern, renal function). This page treats the three disciplines as one connected system.
The three disciplines
Each discipline opens with the same three tabs: Topics (what you'll cover), Day in life(what shifts actually look like), and Interview samples (real questions from NHS Band 5-7 interviews).
Haematology
- FBC analysis & morphology
- Blood film interpretation
- Iron studies & anaemia workup
- Haematological malignancies
- ISLH-aligned validation rules
Biochemistry
- Clinical chemistry assays
- Metabolic disorder workups
- Endocrine and renal panels
- Assay validation and verification
- POCT integration
Coagulation
- PT, INR and APTT
- D-dimer interpretation
- Thrombophilia screening
- Mixing studies
- Anticoagulant therapy monitoring
Cross-discipline workflow
A real-world example: a major haemorrhage call triggers a chain of activity across all three disciplines plus Transfusion. The lab handover happens in minutes, not hours.
- Step 1MHP activatedClinical teamClinicians recognise major bleeding and call the Major Haemorrhage Protocol. Activation is a clinical decision, not a lab value.
- Step 2Activation callTransfusionTake the call: patient ID, location, contact number. Request a group and screen sample.
- Step 3SamplesHaem + Bioch + CoagFBC, PT/APTT, Clauss fibrinogen, U&E, gas, lactate, ionised calcium.
- Step 4CommsHaematology BMSPhone results such as Hb 58 g/L via SBAR; document time and recipient.
- Step 5IssueTransfusionEmergency group O red cells until the group is known (O RhD negative, K negative for females under 50 or sex unknown), then group-specific. Electronic issue is separate: it needs a valid group and screen and LIMS rules. Plasma, platelets and cryo per BSH 2022 and local pack.
Simplified for illustration. Real protocols vary by Trust; see your local SOP.
Worked example: major haemorrhage
Expand the scenario below to see how Blood Sciences responds in the first 30 minutes of an MHP activation — with timings, tests, and the handover points that get tested in OSPE assessments.
0–5 minutes: protocol activation
- Transfusion: Prepare the local MHP pack. The BSH 2022 major haemorrhage guideline recommends plasma early in trauma at 1:1 with red cells (not beyond 1:2), and at least 1 FFP to 2 red cells in other major bleeding until coagulation results are available. Cryo composition varies (some Trusts include in pack 1, others defer to pack 2 pending fibrinogen). Confirm recipient ID with ED.
- Haematology: Hold any non-urgent QC. Pre-warm coagulation analyser for STAT PT/APTT/fibrinogen.
- Biochemistry: Reserve blood gas / electrolyte slot. Pre-empt likely add-ons (ionised Ca²⁺, lactate, base excess).
5–15 minutes: first samples arrive
- Sample reception: FBC (EDTA), coag (citrate, filled to mark), U&E + gas + lactate (lithium heparin / blood gas), group & save (clotted). Triage all as STAT.
- Haematology: FBC ASAP and phone each result to the clinical lead. While bleeding continues, BSH 2022 advises keeping platelets above 50 × 10⁹/L; this is a transfusion target, separate from the RCPath critical limit of 30 × 10⁹/L.
- Coagulation: PT, APTT, fibrinogen — call cryo recommendation if fibrinogen < 1.5 g/L, or < 2.0 g/L in obstetric haemorrhage (BSH 2022; common after volume resuscitation).
- Biochemistry: U&E to detect hyperkalaemia from rapid transfusion; ionised Ca²⁺ for citrate toxicity threshold; lactate as resuscitation marker.
15–30 minutes: second wave and decision point
- Repeat FBC, coag, gas at 15 min. Communicate trends to clinical lead — not just absolute values.
- Decision point: If fibrinogen falls below 1.5 g/L (2.0 g/L in obstetric haemorrhage), recommend additional cryo. Watch for hypocalcaemia from citrate (commonly flag ionised Ca²⁺ < 1.1 mmol/L for replacement, and treat < 1.0 mmol/L as overt citrate toxicity needing immediate escalation). Watch for pH < 7.2.
- Issue MHP pack 2 if active bleeding continues. Track every product issued — vital for SHOT and end-of-event audit.
What the OSPE marker looks for
- Correct SBAR phone communication of critical values.
- Recognition of citrate, dilutional and electrolyte risks.
- Cross-discipline reasoning — not just "report the number."
- Documentation: time of phone call, who you spoke to, what was agreed.
Disciplines side-by-side
Turnaround targets, key analytes, common interferences and critical-value thresholds across all three Blood Sciences disciplines.
| Turnaround targetTypical NHS Trust SLA | Key analytes | Common interferences | Critical-value thresholdsIndicative — confirm locally |
|---|---|---|---|
Haematology ≤ 60 min (routine), ≤ 30 min (urgent FBC) | FBC, reticulocytes, ESR, blood film, immunophenotyping | Lipaemia (false high MCHC); cold agglutinins (false high MCV / low RBC); microcytes / RBC fragments / schistocytes miscounted by analyser as platelets (false HIGH platelet count); large or clumped platelets miscounted as RBCs (false LOW platelet count, requires film review) | Hb < 50 g/L (< 70 g/L if normocytic); neutrophils < 0.5 or > 50 × 10⁹/L; Plt < 30 × 10⁹/L; blasts or malaria parasites on film (RCPath G158) |
Biochemistry ≤ 60 min (routine), ≤ 20 min (troponin, U&E urgent) | U&E, LFT, bone profile, troponin, glucose, lipids, cardiac/endocrine markers | Haemolysis, icterus, lipaemia, biotin (immunoassay), heterophile antibodies | K⁺ < 2.5 or > 6.5 mmol/L; Glu < 2.5 or > 25 mmol/L; troponin above local 99th centile |
Coagulation ≤ 60 min (routine), ≤ 30 min (urgent PT/APTT) | PT/INR, APTT, fibrinogen, D-dimer, thrombin time, factor assays | Underfilled citrate tube, lipaemia in optical methods, heparin contamination from sampling | INR > 5.0 on warfarin, > 6.5 needs urgent assessment (RCPath G158); RCPath sets no APTT or fibrinogen limit, so these are agreed locally |
IBMS Blood Sciences Specialist Portfolio
Many NHS labs now run combined Blood Sciences services, and the IBMS Specialist Portfolio increasingly expects evidence across the three disciplines — not just in one. Our cross-discipline content is structured to feed portfolio evidence in three categories:
Routine analytical
Day-to-day analysis, QC interpretation, troubleshooting analysers in each discipline.
Specialist case handling
Complex scenarios — discordant results, atypical findings, cross-discipline reasoning.
Service-level contribution
EQA investigation, method validation, SOP authoring, audit participation.
Frequently asked questions
What is Blood Sciences?
Why train Haematology, Biochemistry and Coagulation together?
Does this training cover transfusion crossover?
Is the training OSPE-aligned?
Does this support IBMS Specialist Portfolio?
Master Blood Sciences as one connected system
Integrated training across Haematology, Biochemistry and Coagulation — plus the cross-discipline scenarios that show up in OSPE and the interview room.